- Trials with a EudraCT protocol (4,216)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (372)
Query did not match any clinical trials.
| These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
| Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. | |
| Study title: J Nucl Med. 2001 Aug;42(8):1139-43. Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma. SchÃder H, Meta J, Yap C, Ariannejad M, Rao J, Phelps ME, Valk PE, Sayre J, Czernin J. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28168 |
| Study title: J Nucl Med. 2003 Aug;44(8):1200-9. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, Altman H, Keidar Z, Israel O. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28142 |
| Study title: Yen TC, Chang YC, Chan SC, Chang JT, Hsu CH, Lin KJ, et al.. Epub 2004 Dec 30. Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes? [yen-2005-c]Eur J Nucl Med Mol Imaging. 2005 May;32(5):541-8. Yen TC 2005 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48717 |
| Study title: Comparison of bone and gallium-67 imaging in heroin users' arthritis. Bittini A, Dominguez PL, Martinez Pueyo ML, López Longo FJ, Monteagudo I, Carreño L. J Nucl Med. 1985 Dec;26(12):1377-81. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48464 |
| Study title: Chronic recurrent multifocal osteomyelitis (CRMO) with symmetric involvement of both femora: X-ray, bone scintigram, and MR imaging findings in one case. Buck FM, Treumann TC, Winiker H. Strobel K. J Mag Reson Imaging 2007;26:422-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48467 |
| Study title: Endocr Pract. 2003 Jul-Aug;9(4):273-9. Comment in: Endocr Pract. 2003 Jul-Aug;9(4):324-6. [18F]fluorodeoxyglucose triple-head coincidence imaging as an adjunct to 131I scanning for follow-up of papillary thyroid carcinoma. Gonzalo IT, Itti E, Mlikotic A, Pham le H, Cesar RB, Meignan M, Mishkin FS. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28140 |
| Study title: Eur J Nucl Med Mol Imaging. 2002 Mar;29(3):346-50. CT vs 68Ge attenuation correction in a combined PET/CT system: evaluation of the effect of lowering the CT tube current. Kamel E, Hany TF, Burger C, Treyer V, Lonn AH, von Schulthess GK, Buck A. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28158 |
| Study title: Eur J Nucl Med Mol Imaging. 2003 Apr;30(4):581-7. Epub 2003 Jan 30. Extratemporal hypometabolism on FDG PET in temporal lobe epilepsy as a predictor of seizure outcome after temporal lobectomy. Choi JY, Kim SJ, Hong SB, Seo DW, Hong SC, Kim BT, Kim SE. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28152 |
| Study title: Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):396-402. Epub 2003 Jan 9. Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumours. Lassen U, Daugaard G, Eigtved A, Højgaard L, Damgaard K, Rørth M. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28149 |
| Study title: Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1064-72. Epub 2004 Mar 11. Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors. Tian M, Zhang H, Oriuchi N, Higuchi T, Endo K. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28131 |
| Study title: Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1073-80. Epub 2004 Mar 9. Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET. Ng SH, Chang JT, Chan SC, Ko SF, Wang HM, Liao CT, Chang YC, Yen TC. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28133 |
| Study title: Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1105-13. Epub 2004 Mar 9. Non-malignant FDG uptake in infradiaphragmatic adipose tissue: a new site of physiological tracer biodistribution characterised by PET/CT. Bar-Shalom R, Gaitini D, Keidar Z, Israel O. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28132 |
| Study title: Eur J Nucl Med Mol Imaging. 2004 Jun;31(6):811-9. Epub 2004 Feb 5. Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology. Amthauer H, Denecke T, Rau B, Hildebrandt B, Hünerbein M, Ruf J, Schneider U, Gutberlet M, Schlag PM, Felix R, Wust P. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28135 |
| Study title: Eur J Nucl Med Mol Imaging. 2005 Dec;32(12):1422-8. Epub 2005 Aug 31. Respiratory motion artefact in the liver dome on FDG PET/CT: comparison of attenuation correction with CT and a caesium external source. Papathanassiou D, Becker S, Amir R, Menéroux B, Liehn JC. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28098 |
| Study title: J Pediatr Hematol Oncol. 2006 Aug;28(8):501-12. Correlative imaging strategies implementing CT, MRI, and PET for staging of childhood Hodgkin disease. Furth C, Denecke T, Steffen I, Ruf J, Voelker T, Misch D, Vondran F, Plotkin M, StÃver B, Henze G, Lemke AJ, Amthauer H. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28078 |
| Study title: Klin Padiatr. 2003 May-Jun;215(3):146-50. [18-FDG-PET-findings in children and adolescents with Hodgkin's disease: retrospective evaluation of the correlation to other imaging procedures in initial staging and to the predictive value of follow up examinations] [Article in German] Wickmann L, Lüders H, DÃrffel W. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28146 |
| Study title: Open clinical study in MRI (Magnetic Resonance Imaging) to demonstrate the tolerance and efficacy of Gd-DTPA (Gadolinium Diethylene triamine penta acetic Acid) in the whole body |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_87054_study_synopsis.pdf |
| View full study record |
| Document reference: 28821 |
| Study title: Open label study of Gadopentetate Dimeglumine as a magnetic resonance imaging (MRI) contrast agent in pediatric patients presenting with symptoms of central nervous system (CNS) lesions. |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_88492_study_synopsis.pdf |
| View full study record |
| Document reference: 28831 |
| Study title: Open uncontrolled study on the safety and efficacy of Gd-DTPA (SH L 451 AA) in magnetic resonance imaging of musculo-skeletal lesions in children and teenage patients (6-18 years) |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28829 |
| Study title: Open-Label Study of Gadopentetate Dimeglumine as an magnetic resonance imaging (MRI) contrast agent in pediatric patients presenting with symptoms of central nervous system lesions. |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_88493_study_synopsis.pdf |
| View full study record |
| Document reference: 28832 |
| Study title: Time resolved contrast enhanced MR angiography of the hand with parallel imaging and view sharing: initial experience; Brauck K; Eur. Radiol.; 2007 vol.17 p.183-192Time resolved contrast enhanced MR angiography of the hand with parallel imaging and view sharing: initial experience; Brauck K; Eur. Radiol.; 2007 vol.17 p.183-192 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28867 |
| Study title: Open-label, multicenter trial of Magnevist® enteral in magnetic resonance imaging of patients |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): ME90095 ME91005 ME91006.pdf |
| View full study record |
| Document reference: 28825 |
| Study title: A Prospective Blinded Read to Explore the Efficacy of MULTIHANCE and MAGNEVIST (0.10 mmol/kg) in Magnetic Resonance Imaging (MRI) of Brain and Spine Tumors in Pediatric Population |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28722 |
| Study title: Open, uncontrolled study on the safety and efficacy of Gd-DTPA (SH L 451 AA) in magnetic resonance imaging (MRI) of CNS lesions in children (6 to 12 years) |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_86238_study_synopsis.pdf |
| View full study record |
| Document reference: 28820 |
| Study title: Open, uncontrolled study on the safety and efficacy of Gd-DTPA (SH L 451 AA) in magnetic resonance imaging of musculo-skeletal lesions in children and teenage patients, 16-18 years (phase III) |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_87191_study_synopsis.pdf |
| View full study record |
| Document reference: 28822 |
| Study title: Open, uncontrolled study on the safety and efficacy of Gd-DTPA (SH L 451 AA) in magnetic resonance imaging (MRI) of brain lesions in children (2-6 years) (phase III). |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_87224_study_synopsis.pdf |
| View full study record |
| Document reference: 28823 |
| Study title: Uncontrolled multicentre study for the further demonstration of the tolerance and efficacy of dimeglumine gadopentatate on intravenous use in magnetic resonance imaging in adults |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_86110_study_synopsis.pdf |
| View full study record |
| Document reference: 28816 |
| Study title: Contrast Enhanced Magnetic Resonance Imaging of the Central Nervous System in Patients Between 2 and 18 Years of Age by Intravenous Administration: A Randomized Double-Blind Comparison of Gadodiamide Injection (Gd DTPA BMA) 0.1 mmol/kg with MAGNEVIST®(G d DTPA) 0.1 mmol/kg |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): SW1357 Redacted.pdf |
| View full study record |
| Document reference: 47577 |
| Study title: Contrast Enhanced Magnetic Resonance Imaging of the Central Nervous System in Patients Between 2 and 18 Years of Age by Intravenous Administration: A Randomized Double-Blind Comparison of Gadodiamide Injection (Gd DTPA BMA) 0.1 mmol/kg with MAGNEVIST® (Gd DTPA) 0.1 mmol/kg (Protocol 50678-005, Study B) |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): SW1358 Redacted.pdf |
| View full study record |
| Document reference: 47578 |
| Study title: Contrast Enhanced Magnetic Resonance Imaging of the Central Nervous System in Patients Less Than 2 Years of Age by Intravenous Administration: An Open Label Study of Gadodiamide Injection (Gd DTPA BMA) 0.1 mmol/kg |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): SW1356 Redacted.pdf |
| View full study record |
| Document reference: 47576 |
| Study title: Int J Cardiovasc Imaging. 2005 Apr-Jun;21(2-3):313-22. Comment in: Int J Cardiovasc Imaging. 2005 Apr-Jun;21(2-3):323-4. Contrast-enhanced magnetic resonance angiography of the great arteries in patients with congenital heart disease: an accurate tool for planning catheter-guided interventions. Valsangiacomo Büchel ER, DiBernardo S, Bauersfeld U, Berger F. Int J Cardiovasc Imaging. 2005 Apr-Jun;21(2-3):313-22. Comment in: Int J Cardiovasc Imaging. 2005 Apr-Jun;21(2-3):323-4. Contrast-enhanced magnetic resonance angiography of the great arteries in patients with congenital heart disease: an accurate tool for planning catheter-guided interventions. Valsangiacomo Büchel ER, DiBernardo S, Bauersfeld U, Berger F. |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28808 |
| Study title: J Magn Reson Imaging. 2002 Jan;15(1):31-8. Magnetic resonance imaging of pulmonary parenchymal disease using a modified breath-hold 3D gradient-echo technique: initial observations. Bader TR, Semelka RC, Pedro MS, Armao DM, Brown MA, Molina PL. J Magn Reson Imaging. 2002 Jan;15(1):31-8. Magnetic resonance imaging of pulmonary parenchymal disease using a modified breath-hold 3D gradient-echo technique: initial observations. Bader TR, Semelka RC, Pedro MS, Armao DM, Brown MA, Molina PL. |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28809 |
| Study title: Coarctation of the aorta: pre and postoperative evaluation with MRI and MR angiography: correlation with echocardiography and surgery; Didier D; Int. J. Cardiovasc. Imaging.; 2006 vol.22 p.457-475Coarctation of the aorta: pre and postoperative evaluation with MRI and MR angiography: correlation with echocardiography and surgery; Didier D; Int. J. Cardiovasc. Imaging.; 2006 vol.22 p.457-475 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28871 |
| Study title: Collateral flow in coarctation of the aorta with magnetic resonance velocity mapping: correlation to morphological imaging of collateral vessels; Holmqvist C; JMRI; 2002 vol.15 p.39-46Collateral flow in coarctation of the aorta with magnetic resonance velocity mapping: correlation to morphological imaging of collateral vessels; Holmqvist C; JMRI; 2002 vol.15 p.39-46 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28861 |
| Study title: Diffusion weighted MR imaging sequence in the detection of postoperative recurrent cholesteatoma; Dubrulle F; Radiology; 2006 vol.238 n.2 p.604-610Diffusion weighted MR imaging sequence in the detection of postoperative recurrent cholesteatoma; Dubrulle F; Radiology; 2006 vol.238 n.2 p.604-610 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28868 |
| Study title: Dynamic gadolinium enhanced subtraction MR imaging a simple technique for the early diagnosis of Legg-Calve-Perthes disease: preliminary results;Sebag G; Pediatr. Radiol.; 1997 vol.27 p.216-220Dynamic gadolinium enhanced subtraction MR imaging a simple technique for the early diagnosis of Legg-Calve-Perthes disease: preliminary results;Sebag G; Pediatr. Radiol.; 1997 vol.27 p.216-220 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28852 |
| Study title: Gd-DOTA enhanced MR imaging in two cases of Sturge-Weber syndrome;Lipski S; AJNR; 1990 vol.11 p.690-692Gd-DOTA enhanced MR imaging in two cases of Sturge-Weber syndrome;Lipski S; AJNR; 1990 vol.11 p.690-692 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28840 |
| Study title: Gd-DOTA: chemistry toxicity and clinical results;Bonnemain B; Liver imaging current trends and new techniques; Ferruci J.T. Stark D.D.; Andiver Medical Publishers Boston 1990; p.349-357Gd-DOTA: chemistry toxicity and clinical results;Bonnemain B; Liver imaging current trends and new techniques; Ferruci J.T. Stark D.D.; Andiver Medical Publishers Boston 1990; p.349-357 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28843 |
| Study title: Imaging of cervico-thoracic lymphangiomas in children;Borecky N; Pediatr. Radiol.; 1995 vol.25 p.127-130Imaging of cervico-thoracic lymphangiomas in children;Borecky N; Pediatr. Radiol.; 1995 vol.25 p.127-130 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28850 |
| Study title: Intraarticular diffusion of Gd-DOTA after intravenous injection in the knee: MR imaging evaluation;Drape JL; Radiology; 1993 vol.188 p.227-234Intraarticular diffusion of Gd-DOTA after intravenous injection in the knee: MR imaging evaluation;Drape JL; Radiology; 1993 vol.188 p.227-234 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28847 |
| Study title: Juvenil spondylodiscitis: the value of magnetic resonance imaging a report of two cases; Plasschaert H; Acta. Othop. Belg.; 2004 vol.70 p.627-631Juvenil spondylodiscitis: the value of magnetic resonance imaging a report of two cases; Plasschaert H; Acta. Othop. Belg.; 2004 vol.70 p.627-631 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28866 |
| Study title: Comparison of Safety and Efficacy of Gadobenate Dimeglumine and Gadopentetate Dimeglumine in Magnetic Resonance Imaging of Central Nervous System Disorders in Pediatric Patients. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28721 |
| Study title: Comparison of Safety and Efficacy of Gadobenate Dimeglumine and Gadopentetate Dimeglumine in Magnetic Resonance Imaging of Central Nervous System Disorders in Pediatric Patients. |
| Active substance: GADOBENIC ACID |
| Study summary document link (including results): EUdraCT-datafields for publication-Bracco-MultiHance_B19036036.xls |
| View full study record |
| Document reference: 28800 |
| Study title: Magn Reson Imaging. 1999 Feb;17(2):229-35. Effect of a gadodiamide contrast agent on the reliability of brain tissue T1 measurements. Steen RG, Reddick WE, Ogg RJ, Langston JW. Magn Reson Imaging. 1999 Feb;17(2):229-35. Effect of a gadodiamide contrast agent on the reliability of brain tissue T1 measurements. Steen RG, Reddick WE, Ogg RJ, Langston JW. |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28806 |
| Study title: Pediatr Int. 2000 Jun;42(3):285-8. Assessment of disease activity and extent by magnetic resonance imaging in ulcerative colitis. Nozue T, Kobayashi A, Takagi Y, Okabe H, Hasegawa M. Pediatr Int. 2000 Jun;42(3):285-8. Assessment of disease activity and extent by magnetic resonance imaging in ulcerative colitis. Nozue T, Kobayashi A, Takagi Y, Okabe H, Hasegawa M. |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28805 |
| Study title: Perfusion weighted MR imaging studies in brain hypervascular diseases: comparison of arterial input function extractions for perfusion measurement;Ducreux D; AJNR; 2006 vol.27 p.1059-1069Perfusion weighted MR imaging studies in brain hypervascular diseases: comparison of arterial input function extractions for perfusion measurement;Ducreux D; AJNR; 2006 vol.27 p.1059-1069 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28870 |
| Study title: Prevalence of ovarian adrenal rest tumours and polycystic ovaries in females with congenital adrenal hyperplasia: results of ultrasonography and MR imaging; Stikkelbroeck NMML; Eur. Radiol.; 2004 vol.14 p.1802-1806Prevalence of ovarian adrenal rest tumours and polycystic ovaries in females with congenital adrenal hyperplasia: results of ultrasonography and MR imaging; Stikkelbroeck NMML; Eur. Radiol.; 2004 vol.14 p.1802-1806 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28865 |
| Study title: Sinus pericranii: advantages of MR imaging; Bigot JL; Pediatr. Radiol.; 2000 vol.30 p.710-712Sinus pericranii: advantages of MR imaging; Bigot JL; Pediatr. Radiol.; 2000 vol.30 p.710-712 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28858 |
| Study title: Soft tissue signal abnormality associated with eosinophilic granuloma correlation of MR imaging with pathologic findings;Monroc M; Pediatr. Radiol.; 1994 vol.24 p.328-332Soft tissue signal abnormality associated with eosinophilic granuloma correlation of MR imaging with pathologic findings;Monroc M; Pediatr. Radiol.; 1994 vol.24 p.328-332 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28849 |
| Study title: Subjective and objective image qualities: a comparison of sagittal T2-weighted spin-echo and turbo-spin-echo sequences in magnetic resonance imaging of the spine by use of a subjective ranking system;Gorres G; Rontgenpraxis; 1998 vol.51 p.258-265Subjective and objective image qualities: a comparison of sagittal T2-weighted spin-echo and turbo-spin-echo sequences in magnetic resonance imaging of the spine by use of a subjective ranking system;Gorres G; Rontgenpraxis; 1998 vol.51 p.258-265 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28853 |
| Study title: Sedation of children undergoing CT and MR imaging: the association of oral hydroxyzine and rectal chloral hydrate. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPF97B1206.pdf |
| View full study record |
| Document reference: 29243 |
| Study title: A functional magnetic resonance imaging study of the long-term influences of early indomethacin exposure on language processing in the brains of prematurely born children. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29804 |
| Study title: Piepsz A, Hahn K, Roca I, Ciofetta G, Toth G, Gordon I et al. A radiopharmaceuticals schedale for imaging in paediatrics. [piepsz-1990]Eur J Nucl Med 1990;17 : 127 – 129. Piepsz A 1990 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48690 |
| Study title: Pirotte B, Goldman S, Dewitte O, Massager N, Wikler D, Lefranc F, et al.. Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures. [pirotte-2006]J Neurosurg. 2006 Feb;104(2):238-53. Pirotte B 2006 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48691 |
| Study title: Procedure Guideline for Tumor Imaging Using Fluorine- 1 8-FDGJ Nucl Med 1998; 3&13&1305. Heinrich R. Schelbert, Carl K. Hoh, Henry D. Royal, Manuel Brown, Magnus N. Dahlbom, Farrokh Dehdashti and Richard L. Wahl |
| Active substance: Steripet |
| Study summary document link (including results): schelbert-1998.pdf |
| View full study record |
| Document reference: 48744 |
| Study title: Extravasation from venous catheter: a serious complication potentially missed by lung imaging.Spicer KM 1983 J Nucl Med. 1983Nov;24(11):1023-6. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): Spicer 1983.pdf |
| View full study record |
| Document reference: 48788 |
| Study title: Q Clinical impact of fluorine-18fluorodeoxyglucose positron emission tomography in cancer patients. A comparative study between dedicated camera and dual-head coincidence gamma camera.JNucl Med Mol Imaging. 2006 Mar;50(1):68-77. Andrieux A 2006 |
| Active substance: SteriPET |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48624 |
| Study title: Schifter T, Hoffman JM, Hatten HP Jr, Hanson MW, Coleman RE, DeLong GR.. Neuroimaging in infantile autism. [schifter-1994]J Child Neurol. 1994 Apr;9(2):155-61. Schifter T 1994 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48695 |
| Study title: Bar-Shalom R, Gaitini D, Keidar Z, Israel O.. Non-malignant FDG uptake in infradiaphragmatic adipose tissue: a new site of physiological tracer biodistribution characterised by PET/CT. [bar-shalam-2004Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1105-13. Epub 2004 Mar 9. Bar-Shalom R 2004 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48628 |
| Study title: Boellaard R, Oyen WJ, Hoekstra CJ, Hoekstra OS, Visser EP, Willemsen AT, Arends B, Verzijlbergen FJ, Zijlstra J, Paans AM, Comans EF,. The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. [boellaard-2008]Pruim J Eur J Nucl Med Mol Imaging 2008 12:2320–2333. Boellaard R 2008 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48633 |
| Study title: Borgwardt L, Højgaard L, Carstensen H, Laursen H, Nowak M, Thomsen C, et al.. Increased fluorine-18 2-fluoro-2-deoxy-Dglucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion. [borgwardt-2005]J Clin Oncol. 2005 May 1;23(13):3030-7. Borgwardt L 2005 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48634 |
| Study title: Brenner W, Friedrich RE, Gawad KA, Hagel C, von Deimling A, de Wit M, et al.. Epub 2006 Jan 11. Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours. [brenner-2006]Eur J Nucl Med Mol Imaging. 2006 Apr;33(4):428-32. Brenner W 2006 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48635 |
| Study title: Children with macrocrania : clinical and imaging predictors of disorders requiring surgery; MEDINA LS; AJNR; 2001 vol.22 p.564 570Children with macrocrania : clinical and imaging predictors of disorders requiring surgery; MEDINA LS; AJNR; 2001 vol.22 p.564 570 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30399 |
| Study title: Optimal imaging strategy for community-acquired Staphylococcus aureus musculoskeletal infections in children.Browne LP, Mason EO, Kaplan SL, Cassady CI, Krishnamurthy R, Guillerman RP. Pediatr Radiol 2008;38:841-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48583 |
| Study title: Primary septic arthritis in heroin users: early diagnosis by radioisotopic imaging and geographic variations in the causative agentsLopez-Longo FJ. Menard HA. Carreno L. eosin J. Ballesteros R. Monteagudo I. J Rheumatol 1987 Oct;14(5):991-4 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48499 |
| Study title: Contrast agents in neuroimaging; BYRD SE; Neuroimaging Clinics North America; 1994 vol.4 n.1 p.9 26Contrast agents in neuroimaging; BYRD SE; Neuroimaging Clinics North America; 1994 vol.4 n.1 p.9 26 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30404 |
| Study title: Choi SJ, Kim JS, Kim JH, Oh SJ, Lee JG, Kim CJ, et al.. Epub 2005 Feb 15. [18F]3'-deoxy-3'- fluorothymidine PET for the diagnosis and grading of brain tumors. [choi-2005]Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):653-9. Choi SJ 2005 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48637 |
| Study title: Nonspecific osteomyelitis in childhood and adolescence. The contribution of imaging diagnosisUrso S, Pacciani E, Fariello G, Colajacomo M, Fassari FM, Randisi F, et al. Radiol Med 1995 Sep;90(3):212-8 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48763 |
| Study title: Radionuclide imaging in bilateral os trigonum syndrome in a young athlete. Minoves M, Company A, Ardevol J, Matas RB, Costansa JM, Setoain J, Domenech-Torné FM. Clin Nucl Med. 2001 Mar;26(3):237-8. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43458 |
| Study title: Radionuclide imaging in the evaluation of osteomyelitis and septic arthritis.Kim EE, Haynie TP, Lowry PA, Harle TS. Crit Rev Diagn Imaging 1989; 29(3):257-305 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48751 |
| Study title: Clinical Performance of PET/CT in Evaluation of Cancer: Additional Value for Diagnostic Imaging and Patient ManagementRachel Bar-Shalom, MD1; Nikolai Yefremov, MD1; Ludmila Guralnik, MD2; Diana Gaitini, MD2,3; Alex Frenkel, DSc1; Abraham Kuten, MD3,4; Hernan Altman, MBA5; Zohar Keidar, MD, PhD1; and Ora Israel, MD1,3. THE JOURNAL OF NUCLEAR MEDICINE • Vol. 44 • No. 8 • August 2003 |
| Active substance: Steripet |
| Study summary document link (including results): bar-shalom-2003.pdf |
| View full study record |
| Document reference: 48623 |
| Study title: Early Irradiation Effects Observed on Magnetic Resonance Imaging and Angiography, and Positron Emission Tomography for Arteriovenous Malformations Treated by Gamma Knife Radiosurgery. Stereotact Funct Neurosurg 1995;61(suppl1):25S-269. 1VY Glio? D.H.C. Pollb, R.S. Lilic, 1VY Cll~i~lCg.Y~ ,S llio1~~, S.S. Cllalgc, C.Y Cllo~lgK~;,Y CIze~zS~.,H . Yellc, L.S. Leeb |
| Active substance: Steripet |
| Study summary document link (including results): guo-1994.pdf |
| View full study record |
| Document reference: 48730 |
| Study title: Effect of Whole-Body 18F-FDG PET Imaging on Clinical Staging and Management of Patients with Malignant LymphomaJ Nucl Med 2001; 42:1139–1143. Heiko Scho¨der, Joubin Meta, Cecilia Yap, Maryam Ariannejad, Jyotsna Rao, Michael E. Phelps, Peter E. Valk, Jim Sayre, and Johannes Czernin |
| Active substance: Steripet |
| Study summary document link (including results): schoder-2001.pdf |
| View full study record |
| Document reference: 48745 |
| Study title: Reiman RE, Rosen G, Gelbard AS, Benua RS, Laughlin JS. Imaging of primary Ewing sarcoma with 13N-L-glutamate. Radiology. 1982 Feb;142(2):495-500. Reiman RE, Rosen G, Gelbard AS, Benua RS, Laughlin JS. Imaging of primary Ewing sarcoma with 13N-L-glutamate. Radiology. 1982 Feb;142(2):495-500. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44093 |
| Study title: Clin Nucl Med. 1999 Jun;24(6):435-9. Tc-99m DTPA used as reference imaging to evaluate the distribution of other tumor-seeking tracers in tumors associated with neurofibromatosis. Suga K, Hirabayashi A, Kishimoto K, Kume N, Matsumoto T, Matsunaga N. Clin Nucl Med. 1999 Jun;24(6):435-9. Tc-99m DTPA used as reference imaging to evaluate the distribution of other tumor-seeking tracers in tumors associated with neurofibromatosis. Suga K, Hirabayashi A, Kishimoto K, Kume N, Matsumoto T, Matsunaga N. |
| Active substance: THALLIUM 201T1 CHLORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44556 |
| Study title: Thallium-201 scintigraphy in childhood osteosarcoma: Comparison with Technituim-99m MDP and magnetic resonance imaging in the evaluation of chemotherapeutic response.Ilhan IE, Gulin V, Berberoglu S, Kapucuoglu N, Cila A, Eke S. Quantitative Hematol Oncol 2005;22(2):153-62 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48725 |
| Study title: Franzius C, Daldrup-Link HE, Wagner-Bohn A, Sciuk J, Heindel WL, Jurgens H, et al.. FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging. [franzius-2002]Franzius C 2002. Ann Oncol. 2002 Jan;13(1):157-60 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48645 |
| Study title: Furth C, Denecke T, Steffen I, Ruf J, Voelker T, Misch D, et al.. Correlative imaging strategies implementing CT, MRI, and PET for staging of childhood Hodgkin disease. [furth-2006]J Pediatr Hematol Oncol. 2006 Aug;28(8):501-12. Furth C 2006 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48652 |
| Study title: The suspected scaphoid fracture and isotope bone imaging. Brown JN. Injury. 1995 Sep;26(7):479-82. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48836 |
| Study title: The suspected scaphoid fracture and isotope bone imaging.Brown JN. Injury 1995 Sep;26(7):479-82. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48582 |
